Atlas Trials

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Clinical trial NCT05940324 · RECRUITING

Trial details

NCT number
NCT05940324
Sponsor
Stanford University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2024-02-24
Primary completion
2028-11-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.